George: The phase 1/2 study is evaluating a new compound called DCC-3009. It is a drug that was designed specifically to work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback